A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Inclusion Criteria: * Male or female aged 20 to 85; * LDL - C between 130 mg/dL and 250 mg/dL; * TG \< 400 mg/dL; * Who without use of any statin within 2 week prior to the trial; * Informed consent given. Exclusion Criteria: * Known hypersensitivity or history of SAE with another HMG-CoA reductase inhibitor, in particular any history of myopathy; * Active liver disease/severe hepatic impairment(Child-Pugh C,ALT2×ULN); * Treatment with Cyclosporin or any disallowed drug; * Patients with unstable angina pectoris; * Pregnant, lactating women; * Patients who have severe medical condition(s) that in the view of the Investigator prohibits participation in the trial.